82 results
8-K
EX-10.1
INMB
INmune Bio Inc
26 Apr 24
INmune Bio Inc. Announces $9.7 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
4:28pm
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit
8-K
EX-10.1
INMB
INmune Bio Inc
22 Apr 24
Entry into a Material Definitive Agreement
5:10pm
for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit adjustments.
Material Changes; Undisclosed